PATENT CLAIM ANALYSIS

Application Number: 15950707
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "170000"]

Abstract:
Provided are methods and compositions, for treating prostate cancer by administering to a patient in need thereof a therapeutically effective amount of a PARP inhibitor, e.g., niraparib; a therapeutically effective amount of a CYP17 inhibitor, e.g., abiraterone acetate, and a therapeutically effective amount of a glucocorticoid, e.g., prednisone.

Claim (Index 1):
A method for treating a prostate cancer comprising administering to a patient in need thereof a therapeutically effective amount of niraparib, a therapeutically effective amount of abiraterone acetate, and a therapeutically effective amount of prednisone.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 91.0
- Lexical Diversity: 1.75758
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13034340', '14607732', '15551708', '15852551', '15337274']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6982308194490243
- 35 USC 102 Novelty (BERT): 0.5153220308377422
- Combined Prediction Score: 0.6799399405878962
- Mean Citation Score: 276.71241000000003
- Max Citation Score: 306.766
- Similarity Product: 282.78586361694335

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test